A NEW POSSIBILITY FOR PHYSIQUE MANAGEMENT ?

Experts are increasingly focused on retatrutide, a novel drug developed by Eli Lilly, as a possible breakthrough in weight reduction . Unlike many existing approaches, retatrutide is a twin-action agonist targeting both GLP-1 and GIP, chemicals that impact appetite and glucose control . Initial